Viewing Study NCT02833766


Ignite Creation Date: 2025-12-24 @ 4:38 PM
Ignite Modification Date: 2026-01-24 @ 6:35 PM
Study NCT ID: NCT02833766
Status: TERMINATED
Last Update Posted: 2021-09-29
First Post: 2016-07-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Anti-EGFR-immunoliposomes Loaded With Doxorubicin in Patients With Advanced Triple Negative EGFR Positive Breast Cancer
Sponsor: Swiss Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Breast Cancer View
None advanced triple Negative, EGFR positive breast cancer View
None doxorubicin View
None triple negative breast cancer (TNBC) View